Exubera

Pfizer – the Manufacturer

Exubera Report

Pfizer, the manufacturer of the new inhaled insulin dubbed Exubera, is a well known drug manufacturer.  Pfizer discovers, develops, and manufactures many leading prescription medications for humans and animals, as well as other best selling products.

As the manufacturer of Exubera, Pfizer has opened up a world of hope to many diabetics who previously refused insulin injections or wished for another option.  Exubera is an inhaled powder form of insulin that requires pulmonary delivery (directly to the lungs).  It is inhaled in the same fashion as a dose of medication for someone with asthma, and it is then absorbed into the bloodstream.

Pfizer, as the manufacturer of Exubera, spent years researching, revising, and clinically testing its product before even seeking the approval of the Food and Drug Administration.  In January of 2006, all of their hard work finally paid off.  After tracking hundreds of diabetic patients over the course of years to discover the effectiveness of Exubera, the FDA agreed to the safety of the drug.

Pfizer still maintains that Exubera should not be administered to any patient who smokes or has lung disease, and does not promote the safety of the drug for children.  In these categories, approval of the FDA was not even sought.